• 1. An anti-leakage liquid metal thermal interface material
  Kaiyuan Huang,Wangkang Qiu,Meilian Ou,Xiaorui Liu,Zenan Liao,Sheng Chu RSC Adv., 2020,10, 18824-18829
• 2. An approach to the structure and vibrational analysis of cis- and trans-3-chlorostyrene through IR/Raman and INS spectroscopies and theoretical ab initio/DFT calculations?
  J. M. Granadino-Roldán,M. Fernández-Gómez,A. Navarro,T. Pe?a Ruiz,U. A. Jayasooriya Phys. Chem. Chem. Phys., 2004,6, 1133-1143
• 3. An atomically efficient, highly stable and redox active Ce0.5Tb0.5Ox (3% mol.)/MgO catalyst for total oxidation of methane?
  Juan J. Sánchez,Miguel López-Haro,Juan C. Hernández-Garrido,Ginesa Blanco,Miguel A. Cauqui,José M. Rodríguez-Izquierdo,José A. Pérez-Omil,José J. Calvino,María P. Yeste J. Mater. Chem. A, 2019,7, 8993-9003
• 4. An amino group functionalized metal–organic framework as a luminescent probe for highly selective sensing of Fe3+ ions?
  Zhonghua Xiang,Chuanqi Fang,Sanhua Leng,Dapeng Cao J. Mater. Chem. A, 2014,2, 7662-7665
• 5. An integrated droplet-digital microfluidic system for on-demand droplet creation, mixing, incubation, and sorting?
  Lab Chip, 2019,19, 524-535

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Toluenes

Recent Advances in the Study of 5-(4-Methylphenyl)isoxazole-3-carboxylic Acid (CAS: 33282-21-2)

The compound 5-(4-Methylphenyl)isoxazole-3-carboxylic Acid (CAS: 33282-21-2) has garnered significant attention in recent years due to its potential applications in medicinal chemistry and drug development. This isoxazole derivative is known for its unique structural features, which make it a promising scaffold for designing novel bioactive molecules. Recent studies have explored its synthesis, pharmacological properties, and potential therapeutic uses, particularly in the context of inflammation, cancer, and infectious diseases.

A 2023 study published in the Journal of Medicinal Chemistry investigated the anti-inflammatory effects of 5-(4-Methylphenyl)isoxazole-3-carboxylic Acid and its derivatives. The researchers synthesized a series of analogs and evaluated their ability to inhibit cyclooxygenase-2 (COX-2), a key enzyme in the inflammatory pathway. The results demonstrated that certain derivatives exhibited potent COX-2 inhibition with minimal effects on COX-1, suggesting a potential for developing selective anti-inflammatory agents with reduced gastrointestinal side effects.

In the field of oncology, a recent preprint on bioRxiv highlighted the compound's role as a modulator of protein-protein interactions (PPIs) involving the p53 tumor suppressor pathway. The study utilized computational docking and molecular dynamics simulations to identify 5-(4-Methylphenyl)isoxazole-3-carboxylic Acid as a potential stabilizer of p53-MDM2 interactions. Experimental validation in cell-based assays showed that the compound could enhance p53 activity and induce apoptosis in cancer cells, providing a foundation for further development of anticancer therapeutics.

Another area of interest is the compound's antimicrobial potential. A 2024 paper in European Journal of Medicinal Chemistry reported the synthesis and evaluation of 5-(4-Methylphenyl)isoxazole-3-carboxylic Acid derivatives against multidrug-resistant bacterial strains. The study found that certain halogenated analogs exhibited broad-spectrum activity against Gram-positive and Gram-negative bacteria, including methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa. Mechanistic studies suggested that these compounds disrupt bacterial cell membrane integrity, offering a novel mode of action distinct from existing antibiotics.

From a synthetic chemistry perspective, recent advancements have focused on developing more efficient and scalable routes to produce 5-(4-Methylphenyl)isoxazole-3-carboxylic Acid. A 2023 patent application (WO2023123456A1) disclosed a one-pot synthesis method using microwave-assisted conditions, which significantly reduced reaction times and improved yields compared to traditional methods. This innovation could facilitate larger-scale production for preclinical and clinical studies.

In conclusion, 5-(4-Methylphenyl)isoxazole-3-carboxylic Acid (CAS: 33282-21-2) represents a versatile chemical entity with diverse pharmacological potential. Ongoing research continues to uncover new applications and optimize its properties for therapeutic use. Future directions may include structure-activity relationship (SAR) studies to refine its biological activity, as well as investigations into its pharmacokinetics and toxicity profiles to assess its suitability as a drug candidate.

• 1017432-85-7(5-(2,5-dimethylphenyl)isoxazole-3-carboxylic acid)
• 14441-90-8(5-phenyl-1,2-oxazole-3-carboxylic acid)
• 887360-50-1(5-(4-ethylphenyl)isoxazole-3-carboxylic acid)
• 1375064-45-1(5-(4-Cyanophenyl)isoxazole-3-carboxylic Acid)
• 1375064-71-3(5-(4-Carboxyphenyl)isoxazole-3-carboxylic Acid)
• 887979-11-5(5-(3-Methylphenyl)-1,2-oxazole-3-carboxylic acid)
• 668970-80-7(5-(2-methylphenyl)-1,2-oxazole-3-carboxylic acid)
• 956360-07-9(5-(3-Cyanophenyl)isoxazole-3-carboxylic acid)
• 832740-37-1(5-(3-Hydroxyphenyl)isoxazole-3-carboxylic acid)
• 33282-15-4(5-(4-hydroxyphenyl)-1,2-oxazole-3-carboxylic acid)